Molecular Characteristics and Antimicrobial Susceptibility Profiles of Elizabethkingia Clinical Isolates in Shanghai, China

References

• Lin JN, Lai CH, Yang CH, Huang YH, Lin HH. Elizabethkingia bruuniana infections in Humans, Taiwan, 2005–2017. Emerg Infect Dis. 2019;25(7):1412–1414. doi:10.3201/eid2507.18076831211685
   PubMed Web of Science ®Google Scholar
• Frank T, Gody JC, Nguyen LB, et al. First case of Elizabethkingia anophelis meningitis in the Central African Republic. Lancet. 2013;381(9880):1876. doi:10.1016/S0140-6736(13)60318-923706804
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Burian K, Terhes G. Resistance levels and epidemiology of non-fermenting gram-negative bacteria in urinary tract infections of inpatients and outpatients (RENFUTI): a 10-year epidemiological snapshot. Antibiotics (Basel). 2019;8:3.
   Web of Science ®Google Scholar
• Dziuban EJ, Franks JL, So M, Peacock G, Blaney DD. Elizabethkingia in children: a comprehensive review of symptomatic cases reported from 1944 to 2017. Clin Infect Dis. 2018;67(1):144–149.29211821
   PubMed Web of Science ®Google Scholar
• Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol. 2005;55(Pt 3):1287–1293.15879269
   PubMed Web of Science ®Google Scholar
• Kampfer P, Matthews H, Glaeser SP, Martin K, Lodders N, Faye I. Elizabethkingia anophelis sp. nov., isolated from the midgut of the mosquito Anopheles gambiae. Int J Syst Evol Microbiol. 2011;61(Pt 11):2670–2675.21169462
   PubMed Web of Science ®Google Scholar
• Nicholson AC, Gulvik CA, Whitney AM, et al. Revisiting the taxonomy of the genus Elizabethkingia using whole-genome sequencing, optical mapping, and MALDI-TOF, along with proposal of three novel Elizabethkingia species: Elizabethkingia bruuniana sp. nov., Elizabethkingia ursingii sp. nov., and Elizabethkingia occulta sp. nov. Antonie Van Leeuwenhoek. 2018;111(1):55–72.28856455
   PubMed Web of Science ®Google Scholar
• Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY antimicrobial surveillance program (1997–2001). J Clin Microbiol. 2004;42(1):445–448.14715802
   PubMed Web of Science ®Google Scholar
• Teo J, Tan SY, Tay M, et al. First case of E anophelis outbreak in an intensive-care unit. Lancet. 2013;382(9895):855–856.
   Web of Science ®Google Scholar
• Moore LS, Owens DS, Jepson A, et al. Waterborne Elizabethkingia meningoseptica in adult critical care. Emerg Infect Dis. 2016;22(1):9–17. doi:10.3201/eid2201.15013926690562
   PubMed Web of Science ®Google Scholar
• Tai IC, Liu TP, Chen YJ, Lien RI, Lee CY, Huang YC. Outbreak of Elizabethkingia meningoseptica sepsis with meningitis in a well-baby nursery. J Hosp Infect. 2017;96(2):168–171. doi:10.1016/j.jhin.2016.11.01828077242
   PubMed Web of Science ®Google Scholar
• Perrin A, Larsonneur E, Nicholson AC, et al. Evolutionary dynamics and genomic features of the Elizabethkingia anophelis 2015 to 2016 Wisconsin outbreak strain. Nat Commun. 2017;8:15483. doi:10.1038/ncomms1548328537263
   PubMed Web of Science ®Google Scholar
• Lin PY, Chen HL, Huang CT, Su LH, Chiu CH. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia. Int J Antimicrob Agents. 2010;36(5):436–440. doi:10.1016/j.ijantimicag.2010.06.03320933186
   PubMed Web of Science ®Google Scholar
• Lin PY, Chiu CH, Chu C, Tang P, Su LH. Invasion of murine respiratory tract epithelial cells by Chryseobacterium meningosepticum and identification of genes present specifically in an invasive strain. New Microbiol. 2006;29(1):55–62.16608126
   PubMed Web of Science ®Google Scholar
• Bellais S, Poirel L, Naas T, Girlich D, Nordmann P. Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob Agents Chemother. 2000;44(1):1–9. doi:10.1128/AAC.44.1.1-9.200010602714
   PubMed Web of Science ®Google Scholar
• Gonzalez LJ, Vila AJ. Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-beta-lactamase BlaB. Antimicrob Agents Chemother. 2012;56(4):1686–1692. doi:10.1128/AAC.05835-1122290979
   PubMed Web of Science ®Google Scholar
• Jian MJ, Cheng YH, Perng CL, Shang HS. Molecular typing and profiling of topoisomerase mutations causing resistance to ciprofloxacin and levofloxacin in Elizabethkingia species. Peerj. 2018;6:e5608. doi:10.7717/peerj.560830225179
   PubMed Web of Science ®Google Scholar
• Han MS, Kim H, Lee Y, et al. Relative prevalence and antimicrobial susceptibility of clinical isolates of Elizabethkingia species based on 16S rRNA gene sequencing. J Clin Microbiol. 2017;55(1):274–280. doi:10.1128/JCM.01637-1627847376
   PubMed Web of Science ®Google Scholar
• Yoon SH, Ha SM, Kwon S, et al. Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int J Syst Evol Microbiol. 2017;67(5):1613–1617. doi:10.1099/ijsem.0.00175528005526
   PubMed Web of Science ®Google Scholar
• Chew KL, Cheng B, Lin R, Teo J. Elizabethkingia anophelis is the dominant Elizabethkingia species found in blood cultures in Singapore. J Clin Microbiol. 2018;56:3.
   Web of Science ®Google Scholar
• Kenna D, Fuller A, Martin K, et al. rpoB gene sequencing highlights the prevalence of an E. miricola cluster over other Elizabethkingia species among UK cystic fibrosis patients. Diagn Microbiol Infect Dis. 2018;90(2):109–114. doi:10.1016/j.diagmicrobio.2017.10.01429174734
   PubMed Web of Science ®Google Scholar
• Lin JN, Lai CH, Yang CH, Huang YH, Lin HH. Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia Anophelis. . J Antimicrob Chemother. 2018;73(9):2497–2502. doi:10.1093/jac/dky19729846598
   PubMed Web of Science ®Google Scholar
• Jean SS, Hsieh TC, Ning YZ, Hsueh PR. Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica. Int J Antimicrob Agents. 2017;50(4):507–511. doi:10.1016/j.ijantimicag.2017.06.02128705672
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Urban E. Epidemiology and resistance trends of Staphylococcus aureus isolated from vaginal samples: a 10-year retrospective study in Hungary. Acta Dermatovenerol Alp Pannonica Adriat. 2019;28(4):143–147.31855266
   PubMed Web of Science ®Google Scholar
• Jian MJ, Cheng YH, Chung HY, et al. Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis. J Antimicrob Chemother. 2019;74(6):1503–1510. doi:10.1093/jac/dkz04530830171
   PubMed Web of Science ®Google Scholar
• Yum JH, Lee EY, Hur SH, et al. Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea. J Microbiol. 2010;48(3):358–364. doi:10.1007/s12275-010-9308-520571954
   PubMed Web of Science ®Google Scholar
• Rahim GR, Gupta N. Elizabethkingia miricola: discrepancies in identification and antimicrobial susceptibilities. Diagn Microbiol Infect Dis. 2019;94(1):104. doi:10.1016/j.diagmicrobio.2018.11.02530594410
   PubMed Web of Science ®Google Scholar
• Wallet F, Loiez C, Decoene C, Courcol R. Rapid identification of Cardiobacterium hominis by MALDI-TOF mass spectrometry during infective endocarditis. Jpn J Infect Dis. 2011;64(4):327–329.21788710
   PubMed Web of Science ®Google Scholar
• Pulcrano G, Balzaretti M, Grosini A, Piacentini V, Poddighe D. First report of Kocuria marina bloodstream infection unrelated to a central venous catheter: a mini-review on an emerging and under-recognized opportunistic pathogen. Infez Med. 2017;25(1):71–74.28353459
   PubMedGoogle Scholar
• Agarwal S, Kakati B, Khanduri S, Gupta S. Emergence of carbapenem resistant non-fermenting gram-negative bacilli isolated in an ICU of a tertiary care hospital. J Clin Diagn Res. 2017;11(1):C4–C7.
   Google Scholar
• Ko HK, Yu WK, Lien TC, et al. Intensive care unit-acquired bacteremia in mechanically ventilated patients: clinical features and outcomes. PLoS One. 2013;8(12):e83298.24376683
   PubMed Web of Science ®Google Scholar
• Lin JN, Lai CH, Yang CH, Huang YH. Elizabethkingia infections in humans: from genomics to clinics. Microorganisms. 2019;7:9.
   PubMed Web of Science ®Google Scholar
• Choi MH, Kim M, Jeong SJ, et al. Risk factors for Elizabethkingia acquisition and clinical characteristics of patients, South Korea. Emerg Infect Dis. 2019;25(1):42–51.30561316
   PubMed Web of Science ®Google Scholar
• Yung CF, Maiwald M, Loo LH, et al. Elizabethkingia anophelis and association with tap water and handwashing, Singapore. Emerg Infect Dis. 2018;24(9):1730–1733.30124415
   PubMed Web of Science ®Google Scholar
• Agrawal A, Ravikumar R, Varun CN, et al. Global proteome profiling reveals drug-resistant traits in Elizabethkingia meningoseptica: an opportunistic nosocomial pathogen. Omics. 2019;23(6):318–326.31120389
   PubMed Web of Science ®Google Scholar
• Spengler G, Kincses A, Gajdacs M, Amaral L. New roads leading to old destinations: efflux pumps as targets to reverse multidrug resistance in bacteria. Molecules. 2017;22:3.
   Web of Science ®Google Scholar
• Chen GX, Zhang R, Zhou HW. Heterogeneity of metallo-beta-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China. J Antimicrob Chemother. 2006;57(4):750–752.16478797
   PubMed Web of Science ®Google Scholar
• Chan JC, Chong CY, Thoon KC, et al. Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone. J Med Microbiol. 2019;68(8):1167–1172.31199227
   PubMed Web of Science ®Google Scholar
• Woodford N, Palepou MF, Babini GS, Holmes B, Livermore DM. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-beta-lactamase gene, blaB3, in the type strain, NCTC 10016. Antimicrob Agents Chemother. 2000;44(6):1448–1452.10817691
   PubMed Web of Science ®Google Scholar
• Lin JN, Lai CH, Yang CH, Huang YH. Comparison of clinical manifestations, antimicrobial susceptibility patterns, and mutations of fluoroquinolone target genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis isolated in Taiwan. J Clin Med. 2018;7:12.
   Web of Science ®Google Scholar
• Fu Y, Zhang W, Wang H, et al. Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli. BMC Infect Dis. 2013;13:8.23295059
   PubMed Web of Science ®Google Scholar
• Lu T, Zhao X, Li X, et al. Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus. Antimicrob Agents Chemother. 2001;45(10):2703–2709.11557458
   PubMed Web of Science ®Google Scholar
• Huang YC, Lin YT, Wang FD. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia. Int J Antimicrob Agents. 2018;51(1):47–51.28668676
   PubMed Web of Science ®Google Scholar
• Huang YC, Huang YW, Lin YT, Wang FD, Chan YJ, Yang TC. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan. Eur J Clin Microbiol Infect Dis. 2017;36(8):1373–1380.28265817
   PubMed Web of Science ®Google Scholar
• Chang TY, Chen HY, Chou YC, Cheng YH, Sun JR. In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases. Eur J Clin Microbiol Infect Dis. 2019;38(11):2045–2052.31352669
   PubMed Web of Science ®Google Scholar
• Lin PY, Chu C, Su LH, Huang CT, Chang WY, Chiu CH. Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients. J Clin Microbiol. 2004;42(7):3353–3355.15243115
   PubMed Web of Science ®Google Scholar